Glucovance 1.25mg. 250mg Tablet
PDF Leaflet Revision Date: 23 July 2010
Clinical Summary
Quick overview from the medicine insert
Indication
Type 2 diabetes management as initial or second-line therapy.
Dosage (summary)
Start with 1 tablet of Glucovance 250 mg/1.25 mg daily; adjust based on response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation.
Key Drug Interactions
- Miconazole
- Fluconazole
- Phenylbutazone
- Diuretics
- ACE-inhibitors
Contraindications
- Hypersensitivity to components
- Type 1 diabetes
- Renal disease
- Liver disease
- Acute alcohol intoxication
Common side effects
- Hypoglycaemia
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
Counselling Points
- Take with meals
- Monitor blood glucose regularly
- Avoid alcohol
- Recognize hypoglycaemia symptoms
Serious warnings
- Lactic acidosis
- Risk of cardiovascular mortality
- Hypoglycaemia symptoms
Important Disclaimer
The Glucovance 1.25mg. 250mg Tablet professional information leaflet below is the property of Merck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
